FindlayGM, DazaRM, MartinB, et al. (2018) Accurate classification of BRCA1 variants with saturation genome editing. Nature, 562:217-222.
2.
HaapaniemiE, BotlaS, PerssonJ, et al. (2018) CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat Med, 24:927-930.
3.
IhryRJ, WorringerKA, SalickMR, et al. (2018) p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med, 24:939-946.
4.
MarinoND, ZhangJY, BorgesAL, et al. (2018) Discovery of widespread type I and type V CRISPR-Cas inhibitors. Science, 362:240-242.
5.
MenaC (2017) The Genome Editing Report of the National Academy of Sciences and the National Academy of Medicine. Genet Test Mol Biomarkers, 21:203-205.
6.
National Academies of Sciences, Engineering, and Medicine, National Academy of Medicine, National Academy of Sciences, and Committee on Human Gene Editing: Scientific Medical, and Ethical Considerations (2017) Human Genome Editing: Science Ethics, and Governance. Washington, DC: National Academies Press.
7.
RossidisAC, StratigisJD, ChadwickAC, et al. (2018) In utero CRISPR-mediated therapeutic editing of metabolic genes. Nat Med, 24:1513-1518.
8.
WattersKE, FellmannC, BaiHB, et al. (2018) Systematic discovery of natural CRISPR-Cas12a inhibitors. Science, 362:236-239.
